Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Adventist Health launches breakthrough move to promote community well-being


Adventist Health

Adventist Health launches Well-Being Division

“Adventist Health’s launch of the Well-Being Division is an important part of our 10-year transformation strategy to move from a healthcare company to a health company,” —Adventist Health CEO Scott Reiner

Adventist Health today announced the launch of its Well-Being Division, solidifying its commitment to lead a 21st century well-being transformation movement. With this far-reaching change, Adventist Health is further demonstrating its commitment to inspire health, wholeness and hope within the communities it serves.

In keeping with its goals, Adventist Health acquired Blue Zones® in early 2020, marking the first step in the creation of its Well-Being Division, and appointed Ben Leedle, Blue Zones CEO, as division president. This month, the organizations began their first partnership Blue Zones Project, a transformational community-led well-being initiative, in Walla Walla, Washington.

“Adventist Health’s launch of the Well-Being Division is an important part of our 10-year transformation strategy to move from a healthcare company to a health company,” Adventist Health CEO Scott Reiner said. “Our mission to live God’s love calls us to care for communities in ways that measurably and sustainably improve well-being.”

This move marks Adventist Health’s commitment from delivering care to improving well-being and quality of life for entire communities, which in turn improves health outcomes for individuals. It comes at a critical time during the COVID-19 pandemic and is essential to help communities and individuals recover and build long-term resiliency.

The Well-Being Division will identify and impact root causes of well-being. Collectively, it will address needs related to individuals, communities and organizations, and will impact all dimensions of well-being. That will include health, sense of purpose, security and prosperity in order to deliver results through direct interventions and by fostering change to human-made surroundings. This model is designed to improve the health of individuals and communities, and in turn, lower overall healthcare costs.

“I was drawn to Adventist Health’s bold vision to reimagine the future of healthcare, and I am thrilled to be a part of Adventist Health,” Leedle said. “I look forward to championing this vision and working together to further strengthen communities and empower individuals to lead healthier lives. Never before in our lifetimes has there been a greater focus on the behaviors that keep us well. Our faith-based company is poised to elevate this conversation and lead our industry.”

Adventist Health’s strategic vision to improve individual, organizational and community well-being is rooted in the Seventh-day Adventist cultural heritage. Since its inception in the 1840s, the Seventh-day Adventist tradition has encouraged a lifestyle of health and wellness. Additionally, Adventist Health recently acquired Blue Zones®, whose proven, research-based solution improves community well-being by design. The Blue Zones model lifts well-being at the population level by making healthy choices easier in all the places people live, work, learn, pray and play. Working with Blue Zones, the Well-Being Division will empower everyone, everywhere to live longer, better lives.

The work of Blue Zones in more than 50 communities across the United States has been credited with double-digit drops in well-being risk factors such as obesity and smoking, transforming lives and achieving millions of dollars of savings in healthcare costs.

About Adventist Health

Adventist Health is a faith-based, nonprofit integrated health system serving more than 80 communities on the West Coast and Hawaii. Founded on Seventh-day Adventist heritage and values, Adventist Health provides care in hospitals, clinics, home care agencies, hospice agencies and joint-venture retirement centers in both rural and urban communities. Our compassionate and talented team of 36,000 includes associates, medical staff physicians, allied health professionals and volunteers driven in pursuit of one mission: living God’s love by inspiring health, wholeness and hope. Together, we are transforming the American healthcare experience with an innovative, yet timeless, whole-person focus on physical, mental, spiritual and social healing.

About Blue Zones®

Blue Zones uses evidence-based ways to help people live longer, better lives. The company’s work is based on explorations and research done by founder and National Geographic Fellow Dan Buettner, who identified the blue zones regions around the world where people live extraordinarily long and/or happy lives. The original research and findings were released in Buettner’s bestselling books The Blue Zones Solution, The Blue Zones of Happiness, The Blue Zones, Thrive, and Blue Zones Kitchen—all published by National Geographic books. Using original Blue Zones research, Blue Zones Project® works with cities and counties to make healthy choices easier through permanent and semi-permanent changes to the community’s environment, policy, and social networks. Participating communities have experienced double digit drops in obesity and tobacco use and have saved millions of dollars in healthcare costs. Blue Zones was acquired by Adventist Health in 2020. For more information, visit bluezones.com.

Share article on social media or email:

SERVPRO Cleaned’ is the Standard for COVID-19 Sanitation


COVD-19 sanitation San Luis Obispo

SERVPRO of San Luis Obispo is ready to deliver deep defensive viral pathogen cleaning.

The SERVPRO of San Luis Obispo professionals are committed to bringing a higher standard of clean to Central Coast communities.

Certified: SERVPRO Cleaned, means that a higher and safer standard of clean and sanitized has taken janitorial cleaning practices to a new level. Businesses, schools and public institutions of all kinds are now required to meet higher levels of COVID-19 sanitation to open and remain open. SERVPRO of San Luis Obispo is ready to deliver deep defensive viral pathogen cleaning.

A recent study published in Search and Performance Marketing Daily reports that 89-percent of consumers are concerned about returning to “brick and mortar” businesses in light of the COVID-19 pandemic. Even though the public is eager to return to favorite businesses, and business is just as eager to get back to work and serve their customers, there is a concern about health and safety.

The SERVPRO of San Luis Obispo professionals are committed to bringing a higher standard of clean to Central Coast communities. The team certifications that are valuable to COVID-19 sanitation in San Luis Obispo County include:

  • AMRT – Applied Microbial Remediation Technician
  • CCT – Carpet Cleaning Technician
  • HST – Health and safety Technician
  • IICRC Certified Firm
  • OSHA Training
  • SCI/SPI/SEN – Carpet Inspector
  • UFT – Upholstery & Fabric Cleaning Technician

The SERVPRO of San Luis Obispo team applies the unique 3-Cs approach that results in certifying the cleanliness of your business with the Certified: SERVPRO Cleaned shield posted in your front window.

  • Consult: Not all businesses are the same, so a cleaning program is tailored based on the unique needs of each facility.
  • Clean: Based on the agreed plan, an expert deep clean is initiated using our proprietary EPA-Approved Hospital-Grade cleaning solutions and always adhering to the leading level of cleaning and decontamination standards set by the CDC.
  • Certify: The Certified: SERVPRO Cleaned shield tells the public your business has met the stringent CDC standards for COVID-19 sanitation in San Luis Obispo County.

The Certified SERVPRO Cleaned shield means that trained and experienced SERVPRO professionals have performed the job according to proprietary SERVPRO protocols and recognized industry standards (CDC, RIA, IICRC) with EPA approved cleaning products to deliver a SERVPRO certified cleaning experience and result. The public, your customers and employees can enter your business with confidence knowing that the nation’s first choice in cleaning, sanitation and restoration was on the job.

SERVPRO of San Luis Obispo has been serving Central Coast communities since 1990. In addition to providing top level Certified SERVPRO Cleaned services, the company specializes in water and fire damage restoration, decontamination from toxic spills, sewage backup, mold, environmental biochemical exposure for residences, businesses and neighborhoods. The company also works closely with insurance companies to help property owners process insurance claims.

SERVPRO of San Luis Obispo

3661 Sacramento Drive Suite 4

San Luis Obispo, CA 93401

(805) 541-1271

Share article on social media or email:

Clinical Care Options and Global Medical Education Alliance Expands Psychiatric Medical Education to a Global Audience


CCO CME

Clinical Care Options

Partnering with a larger organization with an expanded reach and resources was critical for our growth, and CCO is an exceptional fit. With a shared mission to improve patient lives, we are excited about the opportunities that lie ahead. – Prakash Masand, MD, Chief Executive Officer of GME

Clinical Care Options®, LLC (CCO), a Clinical Education Alliance (CEA) Holdings company, today announced it has acquired Global Medical Education (GME), a nationally recognized provider of continuing education for healthcare professionals primarily focused on psychiatry.

CEA represents a growing alliance of CME/CE provider and services organizations that together improve patient care through the delivery of clinically relevant, evidence‐based educational activities and turnkey solutions. This alliance, consisting of CCO, Practicing Clinicians Exchange, and ProCE, now welcomes GME as the newest strategic partner in this CEA evolution.

“GME has provided free, timely, unbiased, evidence-based continuing medical education from the world’s leading experts to healthcare professionals around the world since 2010,” said Prakash Masand, MD, Chief Executive Officer of GME. “Partnering with a larger organization with an expanded reach and resources was critical for our growth, and CCO is an exceptional fit. With a shared mission to improve patient lives, we are excited about the opportunities that lie ahead.”

“Both GME and CCO share a commitment to educational innovation that enhances clinical practice and improves patient care,” said Dan Cox, Chief Executive Officer of CCO. “GME’s addition to the CCO brand strengthens our commitment to deliver world-class solutions to psychiatric learners worldwide.”

Advisors

Torreya LLP acted as legal counsel for the seller and DLA served as legal counsel for CEA.

About Clinical Care Options

Clinical Care Options, LLC is the global leader in the development of innovative enduring, virtual, and live education. Integrating personalization and moderated social media, CCO provides medical and healthcare education and information for the entire healthcare team with the goal of improving patient outcomes. The leadership of CCO has been a pioneer in the creation of continuing education and decision support resources for healthcare professionals both in the United States and around the globe for more than two decades. For more information, visit http://www.clinicaloptions.com

Contact:

Tradd Sanderson

Director of Marketing

Clinical Care Options

Phone: 1-855-224-2241

Email: tsanderson@clinicaloptions.com

Share article on social media or email:

Breastfeeding Won’t Cause Your Breasts to Sag and Nine other Surprising Facts about Breasts


Dr. Constance Chen

More than any other organ in the human body, the breast occupies a place in our social and cultural landscape well beyond its physiological function to nourish our offspring.

More than any other organ in the human body, the breast occupies a place in our social and cultural landscape well beyond its physiological function to nourish our offspring. “The soft tissue that we think of as a breast is actually a mammary gland, a complex system of fat cells and ducts that produce milk and deliver it to a baby via the nipple,” says plastic surgeon and breast specialist Dr. Constance M. Chen. As much attention as we pay to the size, shape and appearance of a woman’s breasts, there are many fascinating facts – both important and trivial – that most people don’t know about breasts. Here are just a few of them.

1.    Breast size is hereditary. Genetics do play a role in determining breast size but not necessarily as you’d expect and they don’t tell the whole story. We inherit half our genes from each parent, so your breasts may not resemble your mother’s, her mother’s, or her sister’s. Your father’s genes have a say. “Environmental factors also play a role,” says Dr. Chen, “especially weight. Breasts are partly made up of fatty tissue so as you gain and lose weight, your breast size will change.”

2.    Humans are the only primates with permanent breasts. All mammals have breasts and produce milk for their young but we are the only ones who develop breasts at puberty and keep them throughout our lives. Others are temporary, growing when needed to nurse then receding until needed again.

3.    The ancient Egyptians knew about breast cancer as far back as 1600 B.C. Writings on papyrus describe tumors consistent with modern descriptions of the disease. Over the following centuries, many causes were suggested – from imbalances of bodily fluids to compression from tight clothing – and treatments ranged from cauterization to opium to arsenic.

4.    You cannot exercise your way to bigger breasts. “Breasts are made of tissue, not muscle,” says Dr. Chen. “They may change in size with hormonal and weight changes. But even exercising the underlying chest muscles won’t increase the size of your breasts any more than creams or lotions will.”

5.    Some animals get breast cancer. It is more common in dogs – and in some breeds – than in cats but tends to be more aggressive in cats. Spaying female dogs before their first heat dramatically reduces their risk of developing a malignant mammary tumor.

6.    Breastfeeding won’t cause your breasts to sag. Droopy breasts are a natural consequence of aging as skin loses elasticity and as dense breast tissue is replaced by fat, which is more prone to sagging. Smoking and multiple pregnancies are contributing factors but breastfeeding has no effect on elasticity and will not cause breasts to sag. Only corrective surgery can lift sagging breasts.

7.    The left breast is usually slightly larger than the right one. Very few women have perfectly symmetrical breasts. Differences in size up to 20% are normal. No one knows why the left breast is usually the larger one.

8.    Larger breasts don’t produce more milk. Milk production does not depend on the size of the breasts. Large breasts are often large because they contain more fat cells, not more milk-producing cells.

9.    Breasts are growing. The average bra size was 34B twenty years ago. Today, it is 34DD. Some of the change is due to companies inflating the sizes on their labels but increasing obesity, the number of women taking birth control pills, and exposure to environmental pollution are contributing factors.

10.    Breast implants won’t last a lifetime. Breast augmentation is the most commonly performed cosmetic surgery in the U.S. But women who get implants in their 20s should not expect to still have them thirty years later. “Most implants have a ten-year warranty,” says Dr. Chen, “but many develop problems well before then and have to be removed or replaced.”

Constance M. Chen, MD, is a board-certified plastic surgeon with special expertise in the use of innovative natural techniques to optimize medical and cosmetic outcomes for women undergoing breast reconstruction. She is Clinical Assistant Professor of Surgery (Plastic Surgery) at Weill Cornell Medical College and Clinical Assistant Professor of Surgery (Plastic Surgery) at Tulane University School of Medicine. http://www.constancechenmd.com

Share article on social media or email:

Society to Improve Diagnosis in Medicine Presents Mark L. Graber Diagnostic Quality Award to Carmel Crock, MD


“Carmel has almost single-handedly established the diagnostic quality and safety field in Australia and New Zealand,” said David Newman-Toker, MD, PhD, President of SIDM.

The Society to Improve Diagnosis in Medicine (SIDM) today announced that Carmel Crock, MD has been named recipient of the Mark L. Graber Diagnostic Quality Award. The award will be presented today at the Diagnostic Error in Medicine 13th Annual International Conference. The call for nominations received more than 70 submissions for this honor and the Award Review Committee selected Dr. Crock for her research, advocacy and leadership in the field as well as her efforts to expand the field of diagnostic quality and safety internationally.

Dr. Crock is an emergency physician and director of the Emergency Department at the Royal Victorian Eye and Ear Hospital in Melbourne, Australia. She is an associate professor at the University of Melbourne and Chair of the Australasian College for Emergency Medicine Quality and Patient Safety committee. Her education and research interests include preventing diagnostic error, improving healthcare culture and communication, and exploring the relationship between physician wellbeing and patient safety.

Inaccurate and delayed diagnoses are the most common, catastrophic, and costly of medical errors according to an analysis published in BMJ Quality & Safety. It is estimated that 12 million adults in the United States experience a diagnostic error every year in outpatient settings alone, and diagnosis failures result in as many as 80,000 premature deaths every year in U.S. hospitals. Analysis from Dr. Crock in the Medical Journal of Australia found that in Australia, an estimated 140,000 cases of diagnostic error occur each year, with 21,000 cases of serious harm and 2,000–4,000 deaths.

“Carmel has almost single-handedly established the diagnostic quality and safety field in Australia and New Zealand,” said David Newman-Toker, MD, PhD, President of SIDM. “She brings passion, real-world clinical experience, and humility to her efforts to reduce harm from diagnostic error and in doing so is transforming care delivery and improving the health and safety of Australians and New Zealanders. She is a tremendous leader and role model.”

Dr. Crock has been instrumental in raising awareness of the need to reduce diagnostic error in Australia and New Zealand. She was integral to establishing SIDM’s first international affiliate – ANZA-SIDM. In addition, she was the chair of the Australasian Diagnostic Error in Medicine Conference Organizing Committee in 2017 and 2019.

The Mark L. Graber Diagnostic Quality award is given to a person, group, or organization that has made important contributions to the reduction of diagnostic error. The award recognizes either a total body of work (“lifetime achievement”) or a significant contribution in the field and is named in honor of Mark L. Graber, MD, FACP, SIDM Founder.

In nominating her for the honor, colleagues noted:

“Her continued work to improve diagnostic error, and her commitment to the upcoming generation of diagnostic researchers are a testament to her contribution to reducing diagnostic error now and in the future.”

“Carmel is a passionate advocate of diagnostic excellence, shared decision-making and the quality and safety of patient care.”

“As Chair of the Australian College for Emergency Medicine, she informs new policies to reduce diagnostic error in the ER.”

“Carmel’s commitment and passion for improving healthcare is phenomenal and worthy of global recognition.”

“We knew that when we sought to expand the reach of the Society to Improve Diagnosis in Medicine, Carmel was the only choice to chair our ANZA-SIDM affiliate,” added Paul Epner, President and CEO of SIDM. “As the world grapples with a global pandemic, the challenges of accurate and timely diagnosis have come to the fore. Carmel is a true leader in the field and is now on the frontlines helping reduce misdiagnosis of COVID-19.”

###

About the Society to Improve Diagnosis in Medicine (SIDM)

The Society to Improve Diagnosis in Medicine (SIDM) catalyzes and leads change to improve diagnosis and eliminate harm from diagnostic error. We work in partnership with patients, their families, the healthcare community and every interested stakeholder. SIDM is the only organization focused solely on the problem of diagnostic error and improving the accuracy and timeliness of diagnosis. In 2015, SIDM established the Coalition to Improve Diagnosis, to increase awareness and actions that improve diagnosis. Members of the Coalition represent hundreds of thousands of healthcare providers and patients—and the leading health organizations and government agencies involved in patient care. Together, we work to find solutions that enhance diagnostic safety and quality, reduce harm, and ultimately, ensure better health outcomes for patients. Visit http://www.improvediagnosis.org to learn more. Follow us on Twitter and Facebook.

Share article on social media or email:



Pulmonary Hypertension Awareness Month Draws Attention to Life-Threatening, Often Misdiagnosed Disease with Daily Facts


“Educating patients, families, the medical community and policymakers about the symptoms, treatments and challenges of living with PH is essential to improving outcomes and quality of life.”

Pulmonary Hypertension Awareness Month Draws Attention to Life-Threatening, Often Misdiagnosed Disease with Daily Facts

The Pulmonary Hypertension Association’s Discover PH campaign strives to educate others about the disease.

Each November, the Pulmonary Hypertension Association (PHA) launches a national campaign to raise awareness about pulmonary hypertension (PH). The progressive rare disease is defined by high blood pressure in the lungs and can cause right-heart failure and death.

This year, Pulmonary Hypertension Awareness Month focuses on educating people about risk factors and symptoms through an interactive PH Awareness Month calendar. The calendar reveals a new fact or tool daily, along with downloadable resources to raise awareness of PH.

Although it is not known exactly how many people are affected, PH is a contributing factor to more than 18,000 adult deaths in the U.S. every year. It can occur among those with left-heart disease, associated conditions such as sleep apnea, chronic obstructive pulmonary disease (COPD) or scleroderma, or from congenital heart disease. It affects people of any age.

The disease is significantly underdiagnosed and misunderstood, even among health care providers. Symptoms, including shortness of breath, fatigue and chest pain, are not necessarily specific to PH and can lead to dangerous delays in a correct diagnosis. While PH is incurable, early diagnosis and proper treatment can extend and improve an individual’s quality of life.

“It’s critical for us to raise awareness of this rare and life-threatening disease,” said Colleen Brunetti, M.Ed., C.H.C., PHA Board of Trustees chair, who was diagnosed with PH in 2008. “Educating patients, families, the medical community and policymakers about the symptoms, treatments and challenges of living with PH is essential to improving outcomes and quality of life.”

PHA’s outreach during November includes social media, advocacy and educational components such as Facebook Live events with PH experts to drive awareness among those at risk for PH. More information about PH, the campaign and how to spread awareness can be found at: http://www.phassociation.org/awarenessmonth.

PHA is grateful for the sponsorship support provided by Actelion Pharmaceutical U.S., Inc. for Pulmonary Hypertension Awareness Month.

About the Pulmonary Hypertension Association

Headquartered in Silver Spring, Md., the Pulmonary Hypertension Association (PHA) is the country’s oldest and largest nonprofit patient association dedicated to the pulmonary hypertension (PH) community. Pulmonary hypertension is a rare, chronic and life-threatening disease of the lungs for which no cure currently exists. PHA’s mission is to extend and improve the lives of those affected by PH. To achieve this mission, PHA engages people with PH and their families, caregivers, health care providers, and researchers worldwide who work together to advocate for the PH community, provide support to patients, caregivers and families, offer up-to-date education and information on PH, improve quality patient care, and fund and promote research. For more information, visit http://www.PHAssociation.org and connect with PHA on Twitter, Instagram, Facebook and LinkedIn.

Contact:

PHA Communications

communications@phassociation.org

Share article on social media or email:



Green RiNo to Launch First Batch of Live Rosin with In-House Strain


Green RiNo Craft Cannabis

Green RiNo Craft Cannabis

The concentrates market is booming right now. Particularly trending in the cannabis industry is rosin production. From edibles to cartridges and from dabs to pre-rolls, cannabis enthusiasts are clamoring to get their hands on high-quality rosin.

Rosin refers to the extraction process that uses pressure and heat to yield a shatter-like concentrate. Known for its versatility, rosin can be made using either flower or hash and kief. In contrast to its concentrate counterparts, rosin is solventless, which means users do not have to worry about leftover solvents negatively affecting their health or their high.

Green RiNo has long been a proponent of growing high-quality flower that wows their customer base, knowing that it takes careful hands and a true passion to grow flower that has flavor and potency. Taking pride in cultivating the best of the best, Green RiNo has announced that they are coming out with their first batch of live rosin.

Pairing high-quality flower with a carefully chosen extraction lab, Green RiNo is in the midst of running their in-house strain called “Chem De La Chem”. Green RiNo has approached this new endeavor with one priority in mind: team up with producers to bring their top quality flower to the concentrate market.

Known for its gassy flavor and high potency, Chem De La Chem was the perfect choice for their inaugural live rosin strain. Based on the structure and trichome coverage of Chem De La Chem, it provides for high yields and a strong terpene profile. Pricing will vary based on overall characteristics and yields, but should be retailing for an MSRP of $60/g.

In addition to Chem De La Chem, Green RiNo will be releasing Lemon G, Wilson Zero, White Grape Fruit Cookies and an OG to start their journey into the live rosin market. Their entire team is confident that the strategic partnership with the extraction lab will prove to be a fruitful venture for the Green RiNo brand and, more importantly, for its customers base.

As one of the purest forms of concentrated cannabis, live rosin has proven to be a force to be reckoned with in the cannabis industry. Enthusiasts are flocking to stores who carry high quality product that meets or exceeds their high expectations. In fact, High Times has referred to live rosin as the “cannabis concentrate connoisseur’s choice”.

As usual, Green RiNo is on the cutting-edge of the shifts in the industry. With the rosin market starting to accelerate, their ur focus has been to provide strains and flavor profiles that are either currently limited in the market or are nonexistent in the market. In doing so, they aim to offer unique product that never falters on quality.

Share article on social media or email:

Shady Grove Fertility (SGF) Presents 17 Research Abstracts and Receives Awards at the 2020 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo


SGF proudly presents 17 research abstracts at ASRM 2020.

“SGF believes that it is our responsibility to give back to our patients by conducting high-quality research and by training the physicians who will take care of them in the future,” says Dr. Kate Devine.

Shady Grove Fertility’s (SGF) physician-scientists presented exciting, new research findings during the 2020 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo as part of the practice’s commitment to advancing knowledge and improving assisted reproductive technology (ART) treatment outcomes. Hosted virtually this year, the 2020 Scientific Congress and Expo took place October 17-21 and welcomed nearly 10,000 attendees from 94 countries. During a time when much of the world is connected from a distance, this year’s theme of “Dynamic Collaborations in Reproductive Medicine” helped close the physical divide.

SGF: Committed to Research and Education

For the past 29 years, the physicians at SGF have made a sustained commitment to completing clinical research studies and educating physicians in training. SGF is one of only a few private practice fertility centers in the country to employ a full-time dedicated research team, which operates under Director of Research, Kate Devine, M.D., a board certified reproductive endocrinologist who sees patients in SGF’s Washington, D.C., K Street location and is faculty to fellows at the National Institutes of Health (NIH) training to become Reproductive Endocrinologists and to residents at Georgetown School of Medicine training to be Obstetrician/Gynecologists. Many of the studies presented at the meeting this year resulted from collaborations between SGF and academic institutions. SGF physicians act as clinical instructors and research mentors to physicians in training from these institutions.

“SGF believes that it is our responsibility to give back to our patients by conducting high-quality research and by training the physicians who will take care of them in the future,” says Dr. Devine. “The findings of our studies enable us to provide the best possible information and treatment outcomes to those struggling with infertility. The ASRM Scientific Congress and Expo is one of the largest platforms where, year after year, we combine brainpower with fellow professionals to advance modern medicine.”

In addition to Dr. Devine, SGF further expanded its research capabilities with the addition of Anthony Imudia, M.D., Associate Professor of OB/GYN and REI Fellowship Program Director at the University of South Florida Morsani College of Medicine. Dr. Imudia joined SGF in 2019 and sees patients in Tampa Bay’s Wesley Chapel and Westshore, FL, locations. His team of researchers contributed five of the 17 abstracts being presented by SGF this year.

“To better support patients with overcoming infertility, we must understand the root cause from a research perspective so we can tailor our treatment solutions,” explains Dr. Imudia. “Research allows our physicians at SGF to stay at the forefront of making evidence-based fertility treatments possible for patients.”

Remarkably, all 17 abstracts submitted to the ASRM meeting’s scientific program committee were accepted for presentation. SGF’s poster presentation co-authored by SGF reproductive urologist, Cori Tanrikut, M.D., on the analysis of the association between post-wash total motile sperm count and pregnancy from intrauterine insemination (IUI) was lauded as a third-place prizewinner at the event. The study, which analyzed more than 92,000 IUI cycles, provides a highly clinically useful counseling tool. Clinicians can use these data to advise patients with mild male factor infertility regarding their odds of success from IUI so that couples can make informed decisions between low-tech treatment and IVF.

SGF Physicians Recognized for Leadership

In addition to the 17 abstracts presented at ASRM 2020, SGF’s own leadership team took to the virtual stage to present key findings alongside fellow leaders in the field of infertility.

SGF Co-founder and IVF Director for Maryland, Michael Levy, M.D., co-chaired two presentations at the event:

  • “Embryos v. Eggs? Emerging Fertility Preservation Challenges”
  • “The ABOG Foundation – Kenneth J. Ryan Ethics Symposium: Dilemmas in Gamete Donation: Honoring Prior Promises in an Era of Vanishing Anonymity”


Additionally, SGF Chief Medical Officer, Eric Widra, M.D., co-chaired the CME-, PEER-, and ACOG-certified symposium, “Evidence Based Embryo Transfer: Maximizing Implantation.” He also received the ASRM Star Award for sustained research contribution.

Several Abstracts Focus on Understanding Racial and Ethnic Disparities in Fertility Treatment Access and Outcomes

An important focus for SGF researchers this year was to study and understand racial disparities in fertility treatment outcomes and access to care. This has been prioritized as an area of study for the SGF research team year after year. In 2018, SGF authors, including Kate Devine, M.D., and Isaac Sasson, M.D., Ph.D., earned the Health Disparities Special Interest Group Prize Paper for their abstract, “African American patients experience reduced pregnancy, higher pregnancy loss, and lower live birth from in vitro fertilization (IVF) embryo transfers despite producing more oocytes and more transfer quality embryos than comparable Caucasian patients.”

  • Five of the abstracts that were presented by SGF at ASRM in 2020 focus on better understanding differences in access to care and treatment outcomes experienced by minority groups.
  • Two of the abstracts found that both Asian and African American patients experienced lower odds of live birth from donor egg IVF relative to Caucasian patients.
  • In addition, a separate abstract found that East Asian patients undergoing IVF experienced lower odds of live birth from fresh embryos that have not been genetically tested but equivalent outcomes to Caucasians when frozen PGT-A tested (i.e., chromosomally normal) embryos were used, indicating that egg quality may play a role in the lower live birth rates experienced by these patients.
  • Finally, members of SGF’s clinical research team, Renee Hart, M.S. and Samad Jahandideh, Ph.D., teamed up with researchers from the University of Pennsylvania and Duke School of Medicine to present two abstracts presenting data, both objective and subjective (obtained via interviews of SGF patients), regarding the systemic and individual factors that influence whether African American women pursue fertility treatment.


“Women need to be aware of these disparities, and hopefully this awareness will lead them to seek infertility treatment and consultation earlier in their journey to a healthy baby, to maximize chances of success. Furthermore, the more we understand the causes underlying poorer treatment outcomes in minority groups, the more we can work to close the disparity gap,” explains Dr. Devine.

SGF Presents Novel Findings on an Expanding Embryo Donation Treatment Modality that Helps Both Couples and Single Women Achieve their Goal of Having a Family

Additional 2020 SGF abstracts present novel analyses on two important patient populations:

  • Those who elect to donate embryos and
  • Those who endeavor to achieve parenthood by receiving a donated embryo.


The studies seek to elucidate factors that lead patients to donate embryo(s) or to receive donated embryo(s), as well as to better understand outcomes from these embryos. There is little published data on embryo donation, and SGFs growing and successful embryo donation program provided the data for these much-needed analyses. In addition to demonstrating high live birth rates resulting from transfer of donated embryos, SGF’s research demonstrated that women and couples who conceived using donor-embryo IVF were more likely to go on to become embryo donors, perhaps due to a desire to “give back,” so that others may achieve parenthood.

“SGF’s analyses uncovered that 42% of patients who inquired about donating embryos, and 48% of those who ultimately went on to donate, had utilized donor eggs to create those embryos,” explains Dr. Devine. “An impressive 43% of these embryo transfers resulted in successful pregnancies. Embryo donation represents a highly effective and efficient option for women of advanced reproductive age who are unable to conceive with their own eggs, especially those wishing to conceive as single moms by choice,” adds Devine.

Other SGF Findings Presented

  • SGF’s Nancy Durso, M.D., and co-authors found that obese women are less likely to proceed with fertility treatment after an initial consultation with a fertility specialist and that there is a longer average duration before treatment begins for such patients. More effective strategies for actively assisting women in this population to achieve healthy weight loss prior to pregnancy holds potential for improving fertility treatment access, fertility treatment outcomes, and enabling healthy pregnancies and deliveries for moms and babies. SGF’s Wellness Center offers in-house nutrition and wellness services to patients working towards theses goals.
  • SGF’s Jeanne E. O’Brien, M.D., and co-authors analyzed outcomes from gestational carrier cycles based on single vs double embryo transfer, finding that elective single embryo transfer (eSET) is highly successful and that double embryo transfer increases risk for preterm birth and low birth weight, even in the setting of a healthy gestational carrier. Promoting the goal of healthy singleton live birth is particularly important in this population, given that many intended parents still opt to transfer two embryos in the time and cost-intensive setting of working with a gestational carrier.


“SGF holds the goal of ‘one healthy baby at a time’ paramount both in its research and its clinical practice and is a national leader in its utilization and success from eSET, in service of this goal,” shared Devine.

To learn more about ongoing research being conducted at SGF, visit http://www.shadygrovefertility.com/research

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and 5,000+ 5-star patient reviews. With 37 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, deliver individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including 100% refund guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

Oscar Veteran Dr. Patricia Pechter Joins HealthJoy as Chief Medical Officer


HealthJoy, the first and only benefits experience platform, today announces the appointment of Patricia Pechter MD as Chief Medical Officer. A board-certified physician with nine years of experience in primary care, telemedicine, urgent care and health management, Dr. Pechter brings to HealthJoy an extensive background in improving patient outcomes and satisfaction while minimizing unnecessary healthcare costs.

The HealthJoy mobile app gives members access to online medical providers and a team of healthcare concierges that can explain their benefits, recommend providers, resolve billing errors, and more. At the center of the experience is JOY, an AI-powered virtual assistant that helps with year-round benefits education and personalized member outreach. As Chief Medical Officer, Dr. Pechter will oversee clinical care operations and be responsible for identifying additional ways to provide proactive, high-quality care to members while mitigating their healthcare spending. She will also help integrate third-party clinical programs, assist in bringing deeper clinical capabilities to the concierge staff, and improve JOY.

“I’m honored to welcome Dr. Pechter to the HealthJoy team,” Justin Holland, CEO of HealthJoy, said. “She is committed to making healthcare accessible and affordable, and our shared mission will be a major asset in creating a more meaningful healthcare experience for our members. I look forward to working together to drive new outcomes and further simplify the healthcare journey.”

Dr. Pechter has been a pioneer in healthcare technology, previously serving as Medical Director of Virtual Care at Oscar where she spearheaded developing quality assurance programs, establishing onboarding and training curriculum, optimizing provider workflows, and creating personalized member experiences while adhering to clinical best practices. She joined the company as one of three original Virtual Care Physicians.

“2020 proved that consumers want and need virtual care more than ever before. HealthJoy is the perfect entry point for patients because it gives them the education and resources they need to make an informed decision and receive high-quality, affordable care,” Dr. Pechter said. “I’m thrilled to contribute my experience to the HealthJoy team and look forward to accelerating healthcare innovation to create a delightful member experience.”

Dr. Pechter earned a bachelor’s degree from Harvard University and a medical degree from the University of Miami. She completed her residency in Family Medicine at Beth Israel Mt. Sinai Medical Center in New York City and became faculty at NYU as a clinician at their flagship Urgent Care office, leading efforts to customize the EHR for physician efficiency and patient safety.

About HealthJoy

HealthJoy is a first-of-its-kind benefits experience platform helping companies save money on their healthcare while improving employee satisfaction. Through personalized guidance and AI technology, HealthJoy empowers employees to better use and understand their benefits. HealthJoy integrates with a client’s existing benefits package to deliver each employee a personalized, proactive experience. Employees gain access to on-demand medical consultations, live healthcare concierges, prescription savings, and much more. For more information, visit https://www.healthjoy.com.

Share article on social media or email:

InSight + Regroup Introduces Customized ROI Assessments to Help Healthcare Systems Measure Financial Impact of On-Demand Telepsychiatry


InSight + Regroup recently launched a customized value calculator to help hospitals and healthcare systems evaluate costs associated with their current process for managing behavioral health patient demand against savings and revenue opportunities.

The unique tool responds to a long-standing need for hospital administration to quantify the expected return on investment of behavioral health coverage via on-demand telepsychiatry. This new capability comes at a critical time as the industry faces unexpected operational and financial challenges. Many facilities are seeing a rise in demand for mental health services, while experiencing financial strain due to a simultaneous drop in ED visits in the wake of COVID-19.

For hospitals and healthcare systems considering on-demand telepsychiatry to meet growing patient need for mental health services, implementing a financially sustainable and scalable program is essential:

25% of all emergency department visits are due to behavioral health issues

3X longer emergency department boarding times for mental health admissions vs. non-mental health admissions

On-demand telepsychiatry can have a positive financial ripple effect that extends well beyond emergency departments, including reduced reliance on scarce inpatient psychiatric resources, reduced inpatient psychiatric admissions, improved emergency department throughput and increased capacity for med-surg admissions. It allows healthcare systems to allocate resources to populations with heightened need and acuity to reduce strain on clinicians and improve operational metrics.

InSight + Regroup’s value calculator uses proprietary logic based on more than two decades of experience implementing programs and delivering telepsychiatry services within hospitals and health systems. Customizable to organizations of all sizes, the tool uses validated industry data, clinical research and demonstrated outcomes to help organizations determine the financial impact of on-demand telepsychiatry applied to their specific use case. It takes into account actual direct and indirect costs associated with current behavioral health demand within a hospital in order to quantify specific areas of cost savings and highlight untapped revenue opportunities.

Using key data on current behavioral resources and gaps, such as patient length of stay, bed capacity and existing clinical coverage, hospitals and health systems can:

Isolate specific metrics that impact overall cost of care to understand where and how telepsychiatry can drive savings

Compare actual data against industry benchmarks to evaluate the broader impact of telepsychiatry on operational, financial and clinical outcomes

Validate where and how on-demand telepsychiatry is appropriate in a variety of applications across the health system

Provide a clear, customized picture of potential ROI to aid in decision-making and the development of a justifiable business case

“We understand the key role on-demand telepsychiatry can play in helping hospitals deliver financially sustainable care, but it has typically been challenging for leadership to quantify its impact at a detailed level,” says David Cohn, Chief Growth Officer at InSight + Regroup. “Now, this capability allows us to collaborate with healthcare organizations and give them a fresh, detailed view of their current cost exposure and expected operational outcomes and financial returns from on-demand telepsychiatry programming.”

About InSight + Regroup

InSight + Regroup is the leading and largest telepsychiatry service provider in the US with a mission to transform access to quality behavioral health care. InSight + Regroup serves hundreds of organizations and individuals in various settings across the continuum of care with its on-demand, scheduled services and direct-to-consumer (Inpathy) divisions. Given its size, diversity of services and extensive experience and expertise, InSight + Regroup is uniquely positioned to enable scalable telepsychiatry programs across the care continuum. As an industry thought leader, InSight + Regroup has helped shape the field, define the standard of care and advocate for improved telepsychiatry-friendly regulations. To learn more, visit http://www.InSightTelepsychiatry.com and http://www.RegroupTelehealth.com.

Share article on social media or email: